PNC Financial Services Q1 2026 13F Holdings and Activity Report

I. Institutional Overview

PNC Financial Services, a titan in the American financial landscape, reveals through its latest institutional holdings report a portfolio of immense scale and intriguing structural complexity. As of the close of the first quarter of 2026, the institution manages a staggering $173.19 billion in reported equity assets. This valuation places it among the upper echelon of institutional managers, reflecting not only the capital strength of its underlying banking operations but also the vast reach of its asset management and fiduciary services. When we look at the sheer breadth of the portfolio, which encompasses 5,124 individual stocks , we see the hallmark of a "mega-manager"—an institution that likely serves a diverse array of institutional and high-net-worth clients, necessitating a highly diversified approach to capture broad market returns while managing idiosyncratic risks across thousands of positions.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

II. Sector Allocation Analysis

The Healthcare sector, at 48.05% , is the undisputed anchor of the portfolio. This allocation is nearly four times the weight of healthcare in the S&P 500, indicating a massive "overweight" position. From a macro perspective, this suggests a portfolio that is inherently defensive yet tied to high-growth innovation. The institution's judgment seems to be that the secular tailwinds in healthcare—specifically in metabolic health, oncology, and aging demographics—outweigh the cyclical risks of other sectors. However, it is important to note that this is a "lopsided" defensiveness; it is highly dependent on the continued outperformance of a few key players rather than a broad-based bet on hospitals or generic manufacturers.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

III. Top 10 Holdings Deep Dive

At 5.91% of the portfolio, IVV serves as the "core allocation" for broad US equity exposure. This is a strategic position used to ensure the portfolio does not deviate too far from the benchmark index in its non-concentrated portion. The 0.53% reduction in shares is a minor tactical adjustment, likely for liquidity or rebalancing purposes. Interestingly, while the shares decreased slightly, the portfolio weight remained stable, indicating that the underlying performance of the S&P 500 helped maintain its relative importance. This holding reflects PNC’s role as a fiduciary manager, providing its clients with low-cost, efficient access to the broad market while the institution focuses its active management on other areas.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

IV. Major Buys/Additions

The additions this quarter show a distinct pattern: a shift toward International Equities , Artificial Intelligence , and Fixed Income Proxies . The simultaneous additions to ETF-AGG and ETF-GOVT (totaling over $85 million) indicate a "defensive clustering" within the fixed-income sleeve. This suggests that while the institution is aggressive in its equity themes (AI and International), it is also building a more robust "safety net" in high-quality bonds, perhaps anticipating a peak in interest rates or seeking to lock in attractive yields as a hedge against equity volatility.

When we compare these buys to the sells in the next section, a "sell A buy B" strategy emerges. PNC is trimming its "standard" US large-cap exposure (SPY, IVV, AAPL) and its "old-school" defensive healthcare (JNJ) to fund these more targeted, thematic, and international positions. This is a classic "inventory reallocation" where the institution is moving from "passive beta" to "active thematic" and "global alpha" seeking. The overall effect is a portfolio that is becoming more specialized and globally diversified, moving away from the concentrated US-centric model of the past.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

V. Major Sells and Exits

The exits from Hillenbrand (HI) and Amcor (AMCR) , while small in dollar terms relative to the total portfolio, represent a "tail cleanup" or "portfolio slimming." These are mid-cap industrial and materials companies that likely no longer met the institution's liquidity or growth requirements. By liquidating these positions entirely, PNC is reducing the complexity of its 5,000+ stock portfolio and focusing its research and capital on higher-conviction targets. This "slimming" process is essential for a mega-manager to maintain operational efficiency and ensure that every dollar is working toward the primary investment objectives.

The common thread among the reductions is a retreat from "Standard US Beta" and "Legacy Value." The institution is signaling that it no longer wants to be "average" in the US market. By trimming SPY, IVV, and JNJ, it is moving away from the most widely held and "safe" names. The risk signal here is that these areas may face "valuation fatigue." If the largest institutional managers are trimming their core S&P 500 holdings to find growth elsewhere, it suggests a market environment where "stock picking" and "thematic selection" will be more important than simply "owning the index."

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

VI. Investment Insights and Risk Warnings

The logic chain is clear: 1. Sold what : Trimmed redundant S&P 500 exposure (SPY) and legacy defensive healthcare (JNJ). 2. Why sell : To capture profits in high-valuation US assets and reduce exposure to slower-growing "value" names. 3. Bought what : Aggressively added to international developed markets (IDEV), artificial intelligence (AIQ), and AI infrastructure (NVDA). 4. Why buy : To exploit the valuation gap between the US and international markets and to double down on the transformative potential of the AI revolution. 5. Overall change : The portfolio has become more "barbelled"—maintaining its massive idiosyncratic bet on Eli Lilly while shifting its remaining capital toward high-growth themes and global diversification.

For the individual investor, the reference value here lies in the geographic and thematic rotation . PNC’s move into international developed markets suggests that the "US-only" investment playbook may be losing its edge. Furthermore, their commitment to AI through both individual stocks and thematic ETFs reinforces the idea that AI is a multi-year structural trend, not a fleeting bubble. However, investors should be wary of simply imitating the Eli Lilly concentration, as that position likely reflects institutional-specific factors that do not apply to a typical retail portfolio.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

Sources and limitations

This report uses public U.S. Securities and Exchange Commission Form 13F disclosures and structured data maintained by 13F Hub. A 13F filing is a quarter-end snapshot of reportable long positions, is normally published with a delay, and does not disclose every short position, cash balance, bond, derivative, or non-U.S. asset.

Narrative content is prepared from the same-period SEC disclosure and 13F Hub structured data, then checked before publication. This material is for research and education, not personalized investment advice.